| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.15 | 0.3 |